Hemosol Meadowpine Facility

Hemosol Inc.

This 130,000 sf facility for Hemosol included the company’s head office, discovery laboratories, manufacturing facility and warehousing. Hemosol’s R&D areas were located on the 2nd floor and included QC Microbiology, QC Chemistry, Discovery and Cell Culture laboratories, as well as write up areas. The associated support spaces included fumehoods, autoclaves, incubators, a unique flow-through glass wash/dry area, articulated fume extraction arms and a glove box isolator.

The focus of the facility was a large-scale GMP manufacturing area for the production of their blood substitute, Hemolink. The main design objective for the 3-storey facility was to optimize personnel and product flows throughout the facility. The ground floor manufacturing area was organized into pressure zones based on clean corridor concepts, and included Class 100,000, 1000, 100 and 10 clean room manufacturing areas, a sterile filling suite, equipment wash and terminal hepafiltraton throughout.

The design included a multi-storey vertical service chase to organize the extensive process piping and mechanical utilities, as well as to lower life-cycle maintenance costs by providing easy access for the maintenance of the utilities.

In 2008, 2585 Meadowpine Blvd became the head office and manufacturing facility for Therapure Biopharma Ltd. (a privately held contract manufacturing organization). NXL is currently working on the design of several internal renovations, and a large commercial expansion to increase and diversify production capacity.

NXL Architects; SNC Lavalin Pharma; Internorth Engineering

Google Map
Completed 2002
Gross Area 130,000 sf
Construction $90M (IMCL Process Equipment)
Location Mississauga, Ontario